科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CNS 科恩-斯蒂尔斯金融

休市中 02-06 16:00:00 EST

62.71

+0.65

+1.05%

盘后62.71

+0.000.00%

17:50 EST

最高63.16	最低62.32	成交量23.86万
今开62.62	昨收62.06	日振幅1.35%
总市值31.99亿	流通市值17.30亿	总股本5,101万
成交额1,497万	换手率0.87%	流通股本2,758万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CNS","market":"US","secType":"STK","nameCN":"科恩-斯蒂尔斯金融","latestPrice":62.71,"timestamp":1770411600000,"preClose":62.06,"halted":0,"volume":238590,"hourTrading":{"tag":"盘后","latestPrice":62.71,"preClose":62.71,"latestTime":"17:50 EST","volume":49737,"amount":3119008.52,"timestamp":1770418231056,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.010473735095069265,"floatShares":27582175,"shares":51007541,"eps":2.97,"marketStatus":"休市中","change":0.65,"latestTime":"02-06 16:00:00 EST","open":62.62,"high":63.16,"low":62.32,"amount":14965338.96297,"amplitude":0.013535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.97,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1092369600000,"exchange":"NYSE","adjPreClose":62.06,"dividendRate":0.039547,"postHourTrading":{"tag":"盘后","latestPrice":62.71,"preClose":62.71,"latestTime":"17:50 EST","volume":49737,"amount":3119008.52,"timestamp":1770418231056,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9186431540952839,"impliedVol":0.2349,"impliedVolPercentile":0.4542},"requestUrl":"/m/hq/s/CNS","defaultTab":"news","newsList":[{"id":"2609432256","title":"释放pipeline in a drug潜力 NLRP3能否催生下一个“药王”?","url":"https://stock-news.laohu8.com/highlight/detail?id=2609432256","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609432256?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:35","pubTimestamp":1770280559,"startTime":"0","endTime":"0","summary":"近期，英硅智能(03696)宣布提名靶向NLRP3的外周限制性抑制剂ISM5059，该候选药物具有新颖母核，由英硅智能自有Pharma.AI平台驱动设计。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260205/20260205163220_51027.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4135","IBD","LU1169590202.USD","CNS","AD","BBB","BK4132","LU1169589451.USD","PD","BK4023"],"gpt_icon":0},{"id":"2593682434","title":"Silo Pharma, Inc.盘中异动 股价大涨8.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593682434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593682434?lang=zh_cn&edition=full","pubTime":"2025-12-23 05:00","pubTimestamp":1766437200,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日05时00分，Silo Pharma, Inc.股票出现波动，股价大幅上涨8.51%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223050001a46bc7a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223050001a46bc7a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4202","SILO","BK4139","BK4135"],"gpt_icon":0},{"id":"1107912016","title":"科恩-斯蒂尔斯金融宣布2026年一、二、三月的分配","url":"https://stock-news.laohu8.com/highlight/detail?id=1107912016","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107912016?lang=zh_cn&edition=full","pubTime":"2025-12-18 05:00","pubTimestamp":1766005211,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融宣布2026年一、二、三月的分配","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","UTF","BK4135"],"gpt_icon":0},{"id":"1172304311","title":"科恩-斯蒂尔斯金融推出基础设施机会和短期优先证券的主动型ETF","url":"https://stock-news.laohu8.com/highlight/detail?id=1172304311","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172304311?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:48","pubTimestamp":1765378133,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融推出基础设施机会和短期优先证券的主动型ETF","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSPF","BK4135","CSRE","CSNR","CSSD","CNS","CSIO"],"gpt_icon":0},{"id":"1142793926","title":"科恩-斯蒂尔斯金融连续第六年被《养老金与投资》评选为“最佳资产管理工作场所”","url":"https://stock-news.laohu8.com/highlight/detail?id=1142793926","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142793926?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:30","pubTimestamp":1765200627,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融连续第六年被《养老金与投资》评选为“最佳资产管理工作场所”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","CNS"],"gpt_icon":0},{"id":"2586474490","title":"2025年，药企已达成4起超百亿元收购！","url":"https://stock-news.laohu8.com/highlight/detail?id=2586474490","media":"制药网","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586474490?lang=zh_cn&edition=full","pubTime":"2025-11-25 10:28","pubTimestamp":1764037735,"startTime":"0","endTime":"0","summary":"2025年，全球药企收购活动频发。其中，多家跨国巨头围绕弥补核心产品增长短板、补强细分赛道管线等原因，已展开了多笔超百亿元人民币的收购。默沙东92亿美元收购Cidara Therapeutics11月17日消息，默沙东宣布以92亿美元现金收购Cidara Therapeutics，将其处于3期临床试验的主要资产流感预防药物CD388收入囊中。2024年6月，该药已获美国FDA批准上市，作为维持疗法治疗COPD成人患者。据悉，其此次收购旨在进一步扩大强生在实体瘤及前列腺癌治疗领域的业务版图。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112510331395189b86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112510331395189b86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BGHQF631.EUR","LU0795875086.SGD","IE00B3T34201.USD","IE00B2B36J28.USD","IE00B7SZLL34.SGD","LU0985320562.USD","LU1032466523.USD","LU1059921491.USD","LU1074936037.SGD","LU2129689431.USD","LU0058720904.USD","LU1935042991.SGD","LU2129689514.USD","LU0466842654.USD","JNJ","CNS","LU0345769128.USD","LU1585245621.USD","SG9999002224.SGD","LU0234570918.USD","LU1674673691.USD","BK4585","LU1280957306.USD","BK4581","IE00BFXG1179.USD","IE00BKVL7J92.USD","BK4007","IE00BVYPNV92.GBP","IE00B19Z3581.USD","BK4135","LU1061106388.HKD","LU0345770308.USD","LU1066051498.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","BK4532","LU1261432733.SGD","LU0234572021.USD","LU2430703178.SGD","LU0070217475.USD","LU0889566641.SGD","LU0320765646.SGD","LU1244550494.USD","LU0289739699.SGD","LU2592432038.USD","SG9999002232.USD","IE00BBT3K403.USD","LU0912757837.SGD","IE00BN8TJ469.HKD","LU2430703095.HKD"],"gpt_icon":0},{"id":"2586747554","title":"Silo Pharma, Inc.盘中异动 急速上涨5.05%报0.410美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586747554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586747554?lang=zh_cn&edition=full","pubTime":"2025-11-25 02:10","pubTimestamp":1764007827,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日02时10分，Silo Pharma, Inc.股票出现异动，股价大幅拉升5.05%。Silo Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125021028a4b79ba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125021028a4b79ba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","BK4202","BK4139","SILO","CNS"],"gpt_icon":0},{"id":"2583163687","title":"Silo Pharma, Inc.盘中异动 股价大涨5.67%报0.460美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583163687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583163687?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:39","pubTimestamp":1763131199,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日22时39分，Silo Pharma, Inc.股票出现异动，股价急速拉升5.67%。Silo Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Silo Pharma, Inc.公司简介：SILO Pharma Inc是一家处于发展阶段的生物制药公司，开发新型疗法，用于治疗治疗不足的疾病，包括压力引起的精神疾病、慢性疼痛疾病和中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114224000976996ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114224000976996ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4135","BK4202","SILO","BK4139"],"gpt_icon":0},{"id":"1124281397","title":"异动解读 | 科恩-斯蒂尔斯金融盘中大涨5.17%，基础设施基金公司发布认购权发行初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1124281397","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124281397?lang=zh_cn&edition=full","pubTime":"2025-10-18 00:10","pubTimestamp":1760717437,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融今日盘中大涨5.17%，引起市场广泛关注。消息面上，科恩-斯蒂尔斯基础设施基金公司于今日早间宣布了可转让认购权发行的初步结果。分析人士指出，认购权发行的初步结果可能超出市场预期，这反映了投资者对科恩-斯蒂尔斯金融及其基础设施基金的信心。然而，具体的认购情况和资金用途还有待公司进一步披露。投资者应密切关注公司后续公告，以全面评估此次认购权发行对公司未来发展的影响。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CNS"],"gpt_icon":0},{"id":"1134285279","title":"异动解读 | 科恩-斯蒂尔斯金融盘中大涨5.17%，可转让认购权发行结果利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1134285279","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134285279?lang=zh_cn&edition=full","pubTime":"2025-10-18 00:10","pubTimestamp":1760717435,"startTime":"0","endTime":"0","summary":"周五盘中，科恩-斯蒂尔斯金融（股票代码：CNS）股价大涨5.17%，引发市场关注。\n\n据悉，科恩-斯蒂尔斯基础设施基金公司今日早间宣布了可转让认购权发行的初步结果。这一消息被视为利好因素，可能是推动公司股价上涨的主要原因。可转让认购权发行通常被视为公司融资或扩张计划的一部分，表明公司正在积极寻求发展机会。\n\n分析人士指出，可转让认购权发行的成功可能为科恩-斯蒂尔斯金融带来额外的资金支持，有助于公司扩大业务规模或投资新的项目。这一举措可能增强了投资者对公司未来发展前景的信心，从而刺激了股价上涨。然而，具体影响还需要等待公司公布更多细节，投资者应密切关注后续公告。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CNS"],"gpt_icon":0},{"id":"1117535489","title":"科恩-斯蒂尔斯基础设施基金公司宣布可转让认购权发行的初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1117535489","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117535489?lang=zh_cn&edition=full","pubTime":"2025-10-17 20:31","pubTimestamp":1760704268,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯基础设施基金公司宣布可转让认购权发行的初步结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNS","UTF","BK4135"],"gpt_icon":0},{"id":"1183315251","title":"科恩-斯蒂尔斯金融与Lincoln Property就华盛顿特区Tenley零售中心Cityline项目成立合资企业","url":"https://stock-news.laohu8.com/highlight/detail?id=1183315251","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183315251?lang=zh_cn&edition=full","pubTime":"2025-09-19 04:32","pubTimestamp":1758227533,"startTime":"0","endTime":"0","summary":"科恩-斯蒂尔斯金融与Lincoln Property就华盛顿特区Tenley零售中心Cityline项目成立合资企业。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","CNS"],"gpt_icon":0},{"id":"2566988061","title":"美股周三早盘专注于中枢神经系统（CNS）疾病创新疗法研发的生物制药公司Rapport Therapeutics股价重挫此","url":"https://stock-news.laohu8.com/highlight/detail?id=2566988061","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566988061?lang=zh_cn&edition=full","pubTime":"2025-09-10 23:46","pubTimestamp":1757519183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RAPP","CNS","LENZ","BK4139","BK4539","BK4135","BK4007"],"gpt_icon":0},{"id":"2566600190","title":"生物制药公司Rapport重挫18.8%，此前完成2.5亿美元的公开发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2566600190","media":"环球市场播报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566600190?lang=zh_cn&edition=full","pubTime":"2025-09-10 22:54","pubTimestamp":1757516040,"startTime":"0","endTime":"0","summary":"美股周三早盘，专注于中枢神经系统（CNS）疾病创新疗法研发的生物制药公司Rapport Therapeutics（RAPP）股价重挫18.8%，此前该公司以每股26美元的价格完成2.5亿美元的公开发行。\n　　此次发行预计将于2025年9月11日完成，所筹资金将用于支持公司的增长计划。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-09-10/doc-infpzray3944272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4135","CNS","RAPP","BK4007"],"gpt_icon":0},{"id":"2565420688","title":"腾盛博药-B盘中异动 下午盘股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565420688","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565420688?lang=zh_cn&edition=full","pubTime":"2025-09-08 15:21","pubTimestamp":1757316076,"startTime":"0","endTime":"0","summary":"2025年09月08日下午盘15时21分，腾盛博药-B股票出现波动，股价大幅拉升5.29%。腾盛博药-B股票所在的生物技术行业中，整体涨幅为1.31%。其相关个股中，药捷安康-B、圣诺医药-B、中生北控生物科技涨幅较大，振幅较大的相关个股有圣诺医药-B、药捷安康-B、三叶草生物-B，振幅分别为28.26%、24.17%、22.81%。腾盛博药-B公司简介：腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509081521169780a508&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509081521169780a508&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4135"],"gpt_icon":0},{"id":"2562684710","title":"翰森制药盘中异动 大幅下跌3.13%报36.480港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562684710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562684710?lang=zh_cn&edition=full","pubTime":"2025-08-27 09:33","pubTimestamp":1756258390,"startTime":"0","endTime":"0","summary":"2025年08月27日早盘09时33分，翰森制药股票出现异动，股价大幅跳水3.13%。截至发稿，该股报36.480港元/股，成交量136.39万股，换手率0.02%，振幅3.40%。翰森制药股票所在的药品行业中，整体涨幅为0.45%。其相关个股中，泰凌医药、联康生物科技集团、凯莱英涨幅较大，振幅较大的相关个股有翰森制药、德琪医药-B、三生制药，振幅分别为3.40%、3.17%、2.99%。恒瑞医药2025年上半年实现营业收入157.61亿元，同比增长15.88%；归属于上市公司股东的净利润44.50亿元，同比增长29.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082709331194ff439d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082709331194ff439d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4135"],"gpt_icon":0},{"id":"1126353513","title":"Cogstate股价因2025财年业绩上涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126353513","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126353513?lang=zh_cn&edition=full","pubTime":"2025-08-22 12:34","pubTimestamp":1755837284,"startTime":"0","endTime":"0","summary":"神经科学技术公司Cogstate Ltd 在发布2025财年业绩后，股价周五攀升5%。股票今日开盘走高，并在投资者消化公司业绩数据时保持涨势。Cogstate股价今日走高，公司2025财年业绩主要由临床试验收入增长推动。但对于Cogstate股价而言，最大的亮点可能是公司首次派发完全免税股息。Cogstate进入2026财年时已签订3590万美元的合同收入，包括自2025年7月1日以来1410万美元的新销售额。过去12个月，该股累计上涨75%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","CGS.AU","CNS","BK7094"],"gpt_icon":0},{"id":"2561883574","title":"翰森制药25年上半年业绩超预期，公司上调全年指引，全球化进程持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2561883574","media":"招商证券(香港)","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561883574?lang=zh_cn&edition=full","pubTime":"2025-08-20 14:14","pubTimestamp":1755670489,"startTime":"0","endTime":"0","summary":"2025上半年收入超出低双位数增长指引，得益于创新产品组合和BD合作。管理层此前预测肿瘤产品在25年上半年实现21.3%的增长，我们估算其销售额达到37亿元人民币，其中大部分来自阿美乐。管理层维持2025财年阿美乐营收目标为60亿元人民币，并指引其峰值销售额可达80亿元人民币。2030年前推出20余款创新药，覆盖逾40项适应症研发是一项长期投入，公司在25年上半年将其19.4%的收入投入研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820143040a493591f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820143040a493591f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","MSD","CNS"],"gpt_icon":0},{"id":"2561893884","title":"腾盛博药-B盘中异动 早盘大幅下跌5.00%报2.090港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561893884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561893884?lang=zh_cn&edition=full","pubTime":"2025-08-20 11:00","pubTimestamp":1755658817,"startTime":"0","endTime":"0","summary":"2025年08月20日早盘11时00分，腾盛博药-B股票出现波动，股价大幅跳水5.00%。截至发稿，该股报2.090港元/股，成交量372.95万股，换手率0.52%，振幅5.00%。资金方面，该股资金流入284.246万港元，流出476.108万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。腾盛博药-B股票所在的生物技术行业中，整体跌幅为3.42%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082011001894eeaf3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082011001894eeaf3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4135","CNS"],"gpt_icon":0},{"id":"2560162191","title":"翰森制药盘中异动 早盘股价大涨3.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560162191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560162191?lang=zh_cn&edition=full","pubTime":"2025-08-19 09:34","pubTimestamp":1755567259,"startTime":"0","endTime":"0","summary":"2025年08月19日早盘09时34分，翰森制药股票出现波动，股价快速上涨3.13%。翰森制药股票所在的药品行业中，整体涨幅为0.13%。其相关个股中，雅各臣科研制药、翰森制药、先声药业涨幅较大，振幅较大的相关个股有九源基因、联邦制药、雅各臣科研制药，振幅分别为10.17%、9.47%、7.69%。目前，翰森制药在中国产生销售收入的创新药共七款。翰森制药表示，2025年上半年，公司自默沙东收取的BD许可费首付款计入合作收入1.12亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081909342094ec28b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081909342094ec28b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNS","BK4135"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cohenandsteers.com","stockEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.0845},{"period":"6month","weight":-0.1438},{"period":"1year","weight":-0.2978},{"period":"ytd","weight":-0.0011}],"compareEarnings":[{"period":"1week","weight":-0.002},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0293},{"period":"6month","weight":0.0839},{"period":"1year","weight":0.139},{"period":"ytd","weight":0.0128}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cohen & Steers, Inc.于2004年3月17日组织成为一家特拉华州公司。Cohen & Steers, Inc.是一家全球领先的专注于全球房地产证券，全球上市基础建设，实物资产，大市值股票和推荐证券的投资管理公司。该公司同时还为投资者管理投资策略例如对房地产证券投资组合以及私人房地产管理可选的投资策略。公司服务于全世界的机构和个人投资者。公司的收益主要来自接收于开放和封闭互助基金的投资顾问，行政管理，分销以及服务资费以及接收于机构账户的投资顾问资费。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.017702},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.004415},{"month":3,"riseRate":0.714286,"avgChangeRate":0.026775},{"month":4,"riseRate":0.666667,"avgChangeRate":0.052556},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.003122},{"month":6,"riseRate":0.571429,"avgChangeRate":-0.003319},{"month":7,"riseRate":0.619048,"avgChangeRate":0.029905},{"month":8,"riseRate":0.52381,"avgChangeRate":0.008352},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.011439},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.004744},{"month":11,"riseRate":0.636364,"avgChangeRate":0.008954},{"month":12,"riseRate":0.5,"avgChangeRate":0.016009}],"exchange":"NYSE","name":"科恩-斯蒂尔斯金融","nameEN":"Cohen & Steers"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科恩-斯蒂尔斯金融(CNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科恩-斯蒂尔斯金融,CNS,科恩-斯蒂尔斯金融股票,科恩-斯蒂尔斯金融股票老虎,科恩-斯蒂尔斯金融股票老虎国际,科恩-斯蒂尔斯金融行情,科恩-斯蒂尔斯金融股票行情,科恩-斯蒂尔斯金融股价,科恩-斯蒂尔斯金融股市,科恩-斯蒂尔斯金融股票价格,科恩-斯蒂尔斯金融股票交易,科恩-斯蒂尔斯金融股票购买,科恩-斯蒂尔斯金融股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科恩-斯蒂尔斯金融(CNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科恩-斯蒂尔斯金融(CNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}